PROS1 and infection: In this study, all the mutant RBD-Fc proteins maintained a strong in vivo immunogenicity in eliciting robust humoral immune responses and cross-neutralizing antibodies that inhibited the infections of the SARS-CoV-2 pseudovirus expressing wild-type or mutant S proteins.